Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease Jose Luis Górriz; José Ramón González-Juanatey; Lorenzo Facila; Maria Jose Soler; Alfonso Valle; Alberto Ortiz;

Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen; Reem Sayad; Alyaa Khaled Abdelmonem; Katia Latifa; Lina Musallam; Moustafa Abouelkheir; Sherif Mira; Ahmed Awad; Ahmed Afsa; Waleed Nassar; Gehad El Ashal; Mohamed Elmasry; Eshak I. Bahbah;